CADIAN CAPITAL MANAGEMENT LP 13D and 13G filings for MaxCyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-13 6:17 pm Purchase | 2024-12-31 | 13G | MaxCyte, Inc. MXCT | CADIAN CAPITAL MANAGEMENT LP | 9,344,424 8.900% | 1,155,476![]() (+14.11%) | Filing |
2024-11-13 7:14 pm Purchase | 2024-09-30 | 13G | MaxCyte, Inc. MXCT | CADIAN CAPITAL MANAGEMENT LP | 8,188,948 7.800% | 2,544,050![]() (+45.07%) | Filing |
2024-02-14 12:25 pm Purchase | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | CADIAN CAPITAL MANAGEMENT LP | 5,644,898 5.500% | 5,644,898![]() (New Position) | Filing |